David I. Zimmer

David I. Zimmer

Auto-generated profile, based on publicly available information

David I. Zimmer

Department of Otolaryngology‐Head and Neck Surgery, Head and Neck Institute Cleveland Clinic Cleveland Ohio U.S.A.

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Addiction
Verified
Journal Article
Open access
PDF file
DZDavid I. Zimmer
David I. Zimmer
RMRoss McCauley
Ross McCauley
VKVarun Konanki
Varun Konanki
JDJoseph Dynako
Joseph Dynako
NZNuha Zackariya
Nuha Zackariya
MWMark M. Walsh
Mark M. Walsh
Background. Chronic cannabis use has become prevalent with decriminalization, medical prescription, and recreational legalization in numerous US states. With this increasing incidence of chronic cannabis use a new clinical syndrome has become apparent in emergency departments and hospitals across the country, termed Cannabinoid Hyperemesis (CH). CH has been described as cyclical vomiting and abdominal pain in the setting of chronic cannabis use, which is often temporarily relieved by hot showers. CH presents a diagnostic challenge to clinicians who do not have a high clinical suspicion for the syndrome and can result in high costs and resource utilization for hospitals and patients. This study investigates the expenditures associated with delayed CH evaluation and delayed diagnosis. Methods. This is a retrospective observational study of 17 patients diagnosed with CH at three medical centers in the United States from 2010 to 2015, consisting of two academic centers and a community hospital. Emergency department (ED) costs were calculated and analyzed for patients eventually diagnosed with CH. Results. For the 17 patients treated, the total cost for combined ED visits and radiologic evaluations was an average of $76,920.92 per patient. On average these patients had 17.9 ED visits before the diagnosis of CH was made. Conclusion. CH provides a diagnostic challenge to clinicians without a high suspicion of the syndrome and may become increasingly prevalent with current trends toward cannabis legalization. The diagnosis of CH can be made primarily through a thorough history and physical examination. Awareness of this syndrome can save institutions money, prevent inappropriate utilization of healthcare resources, and save patients from unnecessary diagnostic tests.

9 May 2023 in The Laryngoscope
Verified
Journal Article
Open access
DZDavid Zimmer
David Zimmer
GPGilman Plitt
Gilman Plitt
BPBrandon Prendes
Brandon Prendes
JKJamie Ku
Jamie Ku
NSNatalie Silver
Natalie Silver
JSJoseph Scharpf
Joseph Scharpf
Objectives: Tall cell variant (TCV) papillary thyroid cancer (PTC) is a subtype of PTC associated with aggressive tumor behavior, advanced stage, and higher rates of recurrence and mortality. The present study aimed to test an established dynamic risk stratification tool in the TCV population, with the goal of better predicting the postoperative course of these patients.Study Design: Retrospective chart review.Methods: A total of 94 patients with TCV who underwent total thyroidectomy with radioactive iodine ablation were retrospectively reviewed from 1998 through 2020. Biochemical, structural, and overall response to treatment was determined for each patient, based on postoperative thyroglobulin levels and imaging findings. Primary outcomes were locoregional and distant recurrence, presence of disease at final follow‐up, need for additional intervention, and disease‐specific mortality.Results: Patients with TCV who were stratified as having an excellent overall response to treatment had lower rates of locoregional recurrence than indeterminate, biochemical incomplete, and structural incomplete responses (2.0%, 33.3%, 55.0%, and 85.7% at 5 years respectively, p < 0.001). The same was true for distant recurrence as well (2.0%, 9.0%, 35.1%, and 42.9%, p < 0.001). An excellent response was also associated with lower rates of presence of disease at final follow‐up, need for additional intervention, and disease‐specific mortality.Conclusions: Although TCV is an aggressive subtype associated with worse clinical outcomes than classical PTC, patients with an excellent overall response to treatment have significantly improved outcomes when compared to indeterminate, biochemical incomplete, and structural incomplete responses.Level of Evidence: 3 Laryngoscope, 133:2430–2438, 2023

16 January 2021 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
MSMorgan M. Sandelski
Morgan M. Sandelski
SDSarah M. Drejet
Sarah M. Drejet
DZDavid Zimmer
David Zimmer
JYJessica A. Yesensky
Jessica A. Yesensky
MMMichael Moore
Michael Moore
MSMichael W. Sim
Michael W. Sim

31 August 2026 in Clinical Practice and Cases in Emergency Medicine
Verified
Journal Article
Open access
STSamuel Jacob Thomas
Samuel Jacob Thomas
DZDavid I. Zimmer
David I. Zimmer
JLJack H. Langford
Jack H. Langford
Toby BrennerToby Brenner
Toby Brenner
KKKate M. Kelly
Kate M. Kelly
DZDonald F. Zimmer
Donald F. Zimmer
Case presentation: A 57-year-old man with a history of obesity-hypoventilation syndrome, diabetes mellitus, and chronic renal insufficiency was intubated with an 8.0-mm endotracheal tube under video laryngoscopy in the emergency department due to respiratory failure. After successful intubation, bloody secretions were noted in the patient’s mouth. Subsequent examination revealed that the endotracheal tube had caused a through-and-through perforation at the junction of the soft palate and the anterior tonsillar pillar. Because the intubation had been successful, the endotracheal tube was not removed, and the soft palate was transected to free the tube. The patient made an uneventful recovery. Discussion: Soft palate perforation is an uncommon injury that has been reported more frequently with video laryngoscopy than direct laryngoscopy. To prevent this injury and ensure its rapid recognition, it is recommended that the clinician sequentially look at the “5 M’s” during intubation: Mouth–Monitor–Mouth–Monitor–Mouth.